摘要
目的:探讨米非司酮联合利凡诺在中期妊娠引产中的应用效果。方法:收治中期妊娠引产患者208例,随机分成观察组和对照组,各104例。观察组应用米非司酮口服后,利凡诺羊膜腔注射;对照组为利凡诺羊膜腔注射。结果:观察组在产程时间、腹痛、出血量、宫颈裂伤、胎盘残留、引产成功率等方面优于对照组。结论:米非司酮联合利凡诺应用于中期妊娠引产是一种有效、安全、不良反应少的方法,值得临床推广。
Objective:To explore the application effect of mifepristone combined with rivanol in mid pregnancy abortion.Methods:208 patients with mid pregnancy abortion were selected,they were randomly divided into the observation group and the control group with 104 cases in each group.The observation group was given mifepristone and rivanol for amniotic cavity injection;the control group was given rivanol for amniotic cavity injection.Results:In the observation group,time of birth process,labor pain,bleeding,cervical laceration,residue of placenta,the success rate were better than those of the control group.Conclusion:The application of mifepristone combined with rivanol in mid pregnancy abortion was an effective,safe,less side effect method.It was worth the clinical promotion.
出处
《中国社区医师》
2015年第8期59-60,共2页
Chinese Community Doctors
